Universal healthcare proposals generate fierce debate in the United States, and the objections raised against them are not all ideological bluster. Concerns about wait times, physician shortages, restricted drug access, and ballooning government costs draw on real experiences in countries that have adopted single-payer or nationally funded systems. The question is whether those problems are inherent to universal coverage or fixable design flaws, and the evidence paints a more complicated picture than either side typically admits.
Wait Times Are a Documented Problem in Single-Payer Systems
The most visceral concern Americans raise about universal healthcare is the prospect of waiting weeks or months for care they can currently get in days. That fear has a factual basis. Canada’s public healthcare system faces persistent and well-documented delays, with prolonged waits leading to worse physical and mental health outcomes and higher downstream treatment costs.1PubMed Central. Addressing Healthcare Waiting Time Challenges in Canada: Insights From Emerging Initiatives In 2020, Canada had the longest specialist wait times among eleven Commonwealth countries, with 62% of patients needing specialist care waiting a month or more just for an appointment.2PubMed Central. Challenges and impacts from wait times for specialist care identified by primary care providers: Results from the MAAP study cross-sectional survey Those delays span multiple specialties, from psychiatry to orthopedics to gastroenterology.
Surgical wait times tell a similar story. A systematic review comparing brain tumor surgery across countries found that mean hospital stays ran about five days in countries with mixed-payer systems but closer to eight days in single-payer countries.3PubMed Central. A Comparison of Surgery Wait Times and Postoperative Length of Hospital Stay Among Patients with Brain Tumors by Country-Level Income and Healthcare System Longer stays tie up beds, push back the queue for the next patient, and add cost even when the surgery itself goes well. The concern is not that single-payer systems cannot perform surgery competently, but that fixed budgets and capacity constraints create bottlenecks that a more fragmented system can sometimes avoid by routing patients to whichever facility has capacity.
Critics of this argument point out that Americans already experience waits for specialists, particularly in rural areas. That is true. But the structural difference is that in a multi-payer system, patients with good insurance can often buy their way to faster care, which is both an advantage for those patients and a deep equity problem. Universal healthcare trades one set of access barriers (cost) for another (time), and whether that trade-off is acceptable depends on who you ask.
What Happens to Doctors’ Paychecks
Under a Medicare for All-style reform, payment rates for physician services would drop substantially, because Medicare reimburses providers at considerably lower rates than private insurers do. Researchers have noted that this revenue decline could affect physician recruitment, retention, and practice sustainability, potentially worsening existing workforce shortages if providers cannot offset the lower margins by seeing more patients or cutting overhead.4PubMed Central. How Would Medicare for All Affect Physician Revenue?
This is not a hypothetical scenario invented by opponents of reform. American physicians carry enormous educational debt, and the financial structure of medical practice in the U.S. is built around the assumption that private insurance payments will subsidize the lower reimbursements from Medicare and Medicaid. If private insurance disappears overnight and every patient pays at Medicare rates, many practices, particularly small and independent ones, could face genuine financial distress. Some specialties that rely heavily on procedure-based payments would be hit harder than primary care, which could reshape the mix of specialists available to patients.
The counterpoint from universal healthcare advocates is that administrative savings could partially offset the revenue loss. The U.S. healthcare system spent roughly $372 billion on administrative and non-clinical costs in 2024, an amount that has grown at 872% since 1990, far outpacing the growth in hospital care or physician services.5World Journal of Advanced Research and Reviews. The $372 Billion Problem: Healthcare administrative cost, financial inefficiency, and the case for analytics-driven governance in the U.S. Healthcare System A single-payer system, in theory, could slash some of that billing complexity. Whether the savings would be large enough to keep physician income stable is genuinely uncertain, and the transition period would be rocky regardless.
Drug Access Gets Rationed
One of the less-discussed consequences of universal systems is how they manage pharmaceutical costs. When a single entity negotiates drug prices on behalf of an entire population, it gains leverage but also becomes a gatekeeper. Canada provides a clear example. Of 344 drug reimbursement recommendations made by Canada’s drug review agency, only three, less than 1%, received unconditional approval for reimbursement. Roughly 85% were approved with clinical restrictions or price conditions, and about 15% were rejected outright.6PubMed Central. Consequences of Canada’s Drug Agency Reimbursement Recommendations for New Medicines and Pan-Canadian Pharmaceutical Alliance Price Negotiations on Patient Access
For the average patient with common conditions, this may not matter much. The drugs they need are typically covered. But for patients with rare diseases or aggressive cancers who need the newest therapies, the restrictions can be life-altering. Conditional reimbursement often means meeting specific clinical criteria before a drug is approved for you, which can delay treatment or force patients and their doctors into bureaucratic battles to prove eligibility. In the American system, a patient with good insurance can often access a newly approved drug within weeks of its FDA clearance. That speed comes at a price, literally, but it is a tangible advantage the current system offers to those who can afford it.
The broader tension here is between individual access and collective cost control. Every dollar saved through aggressive formulary management is a dollar that keeps the system solvent for everyone else. But telling a patient with a rare condition that the drug their doctor wants to prescribe is not covered, or only covered if they first fail cheaper alternatives, is a real human cost that proponents of universal healthcare sometimes gloss over.
Aging Equipment and Technology Lags
When a healthcare system runs on a fixed national budget, capital investments in new equipment compete directly with every other spending priority, from salaries to drug costs to building maintenance. Italy’s experience illustrates the problem. A study of CT scanners installed across Italian health facilities found persistent and progressive aging of diagnostic equipment, with technology that failed to meet either universal health coverage principles or European standards for advanced screening.7PubMed Central. Universal Access to Advanced Imaging and Healthcare Protection: UHC and Diagnostic Imaging The researchers argued that replacing obsolete scanners should be treated as an investment rather than a cost, but budget-constrained systems often defer those purchases.
The United States, for all its spending inefficiency, leads the world in the adoption and availability of advanced medical technology. MRI machines, PET scanners, robotic surgical systems, and proton beam therapy centers are far more widely distributed per capita in the U.S. than in most universal-coverage countries. Some of that abundance is wasteful, driven by a fee-for-service model that incentivizes facilities to buy expensive machines and then use them aggressively to recoup costs. But it also means that when you need an advanced scan, you are more likely to get one quickly and on a modern machine.
Under a universal system with centralized budgets, the concern is not that technology would vanish but that the pace of adoption and replacement would slow. Decisions about whether to buy a new MRI scanner would be made by administrators balancing competing budget demands, and the MRI might lose to more politically urgent needs like staffing or reducing surgical backlogs. Over years, this kind of deferred investment could erode the diagnostic edge that the U.S. currently holds.
Moral Hazard and Overuse
There is compelling evidence that when people pay less out of pocket for healthcare, they use more of it.8PubMed Central. Moral Hazard in Health Insurance: What We Know and How We Know It Economists call this moral hazard, and it is a standard feature of insurance in general, not just health insurance. When coverage is universal and copays are minimal or zero, the incentive to weigh whether a doctor visit or test is worth the cost largely disappears. A key implication is that this can lead to overuse of low-value care, where the cost to the system exceeds the medical benefit to the patient.9PubMed Central. Behavioral Hazard in Health Insurance
Overuse does not just mean hypochondriacs clogging waiting rooms. It includes unnecessary imaging, redundant specialist referrals, and procedures performed because they are available and free rather than because they change outcomes. Every system with broad coverage, whether universal or not, faces this challenge to some degree. The concern is that stripping out virtually all cost-sharing, as some Medicare for All proposals envision, would amplify it.
There is an important wrinkle here, though. The same research literature shows that cost-sharing also discourages valuable care. People who face high out-of-pocket costs skip medications, delay necessary surgeries, and avoid preventive screenings. The trick is designing a system that discourages low-value use without scaring people away from high-value care, and no country has fully solved that puzzle.
Lessons from the NHS
The United Kingdom’s National Health Service is the most prominent example of a fully government-run healthcare system, and its recent struggles are often cited by American critics of universal care. The NHS faces a cascading set of challenges, including staffing retention problems, growing backlogs for clinic appointments and procedures, an aging population with increasingly complex health needs, and a severe crisis worsened by the COVID-19 pandemic.10PubMed Central. The Emerging Challenges and Strengths of the National Health Services: A Physician Perspective
The post-pandemic backlog has been staggering. Millions of patients in England have waited months for elective procedures, and staff morale has plummeted under chronic underfunding and overwork. Primary care access has deteriorated, with patients struggling to get basic GP appointments. These are not abstract policy concerns; they translate into real suffering for people whose hip replacements, cancer screenings, or mental health treatments are delayed.
It is worth noting that the NHS’s problems are partly a function of chronic underinvestment, not an inevitable feature of universal coverage. Countries like Germany and France run universal systems with far shorter wait times, largely because they spend more per capita and maintain hybrid public-private structures. The NHS is a cautionary tale about what happens when a universal system is underfunded, which is a genuine risk in the American context given political resistance to the tax increases that universal coverage would require.
The Scale of Government Program Fraud
Opponents of expanding government healthcare frequently point to the scale of existing waste in federal programs. In fiscal year 2024, the Government Accountability Office estimated roughly $162 billion in improper payments across 68 federal programs, with about $86 billion concentrated in Medicare, Medicaid, and related health initiatives.11Computer Science & IT Research Journal. Leveraging data analytics and AI to reduce improper payments across U.S. healthcare programs The word “improper” covers a wide range, from outright fraud to documentation errors and eligibility mistakes. The researchers noted that these figures reflect systemic weaknesses in documentation, eligibility verification, and claims accuracy rather than primarily fraud.
Still, $86 billion is a staggering number, and it comes from programs that cover only a fraction of the population. Scaling government-run healthcare to cover all 330 million Americans would presumably scale the administrative errors as well, at least initially. Building the verification and auditing systems to manage universal enrollment would be an enormous undertaking, and the political appetite for the kind of rigorous enforcement needed to hold improper payments in check is historically weak.
The honest comparison, though, requires acknowledging that private insurance is not immune to waste and fraud either. Private insurers spend heavily on claims denial, prior authorization, and utilization management, processes that constitute a different kind of administrative overhead that imposes its own costs on patients and providers alike.
Vermont Tried and Stopped
The closest the United States has come to implementing a state-level single-payer system was Vermont’s Green Mountain Care, championed by Governor Peter Shumlin. The plan was abandoned before implementation. The collapse of Vermont’s single-payer effort drew national attention precisely because it illustrated the practical obstacles to universal coverage in the American context.12New England Journal of Medicine. The demise of Vermont’s single-payer plan
The fundamental problem was cost. Financing the plan would have required tax increases that were politically untenable even in a progressive state. Vermont is small, which made risk pooling less efficient. Businesses pushed back against projected payroll taxes. And the federal waivers needed to redirect Medicare and Medicaid dollars into a state plan proved difficult to secure. The episode showed that even when a state’s political leadership is committed to universal coverage, the fiscal and regulatory realities of the American system create formidable barriers.
Whether Vermont’s failure says something fundamental about single-payer healthcare or something specific about trying to implement it at the state level in a system built around federal programs is still debated. State-level single payer faces a bootstrapping problem: you need federal money to make it work, but the federal government has little incentive to let states experiment with redirecting those funds.
How Employer-Sponsored Insurance Shapes the Labor Market
An often-overlooked dimension of the universal healthcare debate is what the current employer-based system does to American workers. Rising employer-sponsored health insurance premiums have measurable effects on employment. Research using county-level U.S. data found that a 10% increase in premiums reduced employment by about 1.1 percentage points, with the pain concentrated in areas where private insurance coverage was highest.13Review of Economic Analysis. The Effects of Employer-Sponsored Health Insurance Premiums on Employment and Wages: Evidence from US Longitudinal Data Employers facing rising health costs must decide whether to cut benefits, absorb the costs, or compensate by holding wages flat or reducing headcount.14PubMed. Estimating workers’ marginal valuation of employer health benefits: would insured workers prefer more health insurance or higher wages?
This is a genuine cost of the current system that universal healthcare would eliminate. When health insurance is tied to employment, workers face what economists call “job lock,” staying in jobs they would otherwise leave because they cannot afford to lose coverage. Entrepreneurs hesitate to start businesses. People in abusive work environments stay put. The argument against universal healthcare has to account for the economic distortion the current system already imposes. Whatever problems universal coverage might create, the status quo has its own significant labor market costs.
Market-Based Fixes and Their Track Record
If universal healthcare is the wrong answer, what is the right one? The most common market-based proposals center on price transparency and consumer-directed health plans. Price transparency has gained momentum as a policy intervention, with the idea that if patients can compare prices for procedures, market competition will drive costs down.15PubMed Central. Price Transparency in United States’ Health Care: A Narrative Policy Review of the Current State and Way Forward In theory, this makes sense. In practice, compliance with existing transparency rules has been patchy, and most patients do not shop for healthcare the way they shop for a car. Emergency care is not shoppable at all, and even for elective procedures, the complexity of insurance networks and variable out-of-pocket costs makes price comparison genuinely difficult.
Health Savings Accounts, another pillar of the market-based approach, were designed to make consumers more cost-conscious by pairing high-deductible plans with tax-advantaged savings. But research suggests that HSAs no longer meaningfully achieve this goal, largely because cost-sharing has increased so much across all plan types that the distinction between HSA-qualified and conventional plans has blurred. The promised efficiency gains have not materialized, and the tax benefits flow disproportionately to higher earners.16PubMed. Health Savings Accounts No Longer Promote Consumer Cost-Consciousness
This is an uncomfortable reality for opponents of universal healthcare: the market-based alternatives have had decades to prove themselves, and the results are mixed at best. The U.S. spends far more per capita on healthcare than any other wealthy nation while achieving worse population health outcomes on many standard measures. The system’s defenders can reasonably argue that universal coverage would create new problems, but they have a harder time arguing that the status quo is working well.
Who Actually Clogs the Emergency Room
One persistent claim in the healthcare debate is that expanding coverage would overwhelm emergency departments with newly insured patients flooding in for care they previously skipped. The data do not support this narrative. In 2013, about 12.2% of uninsured adults visited an emergency department, compared to 13.7% of insured adults. The average number of ED visits per year was nearly identical between the two groups: 0.18 for uninsured adults and 0.20 for insured adults.17Health Affairs. The Uninsured Do Not Use The Emergency Department More—They Use Other Care Less
The real difference was not in ED use but in use of other care. Uninsured adults were far less likely to see a primary care doctor, fill prescriptions, or get preventive screenings. The problem the uninsured face is not that they overuse emergency rooms but that they underuse everything else. Universal coverage would likely increase demand for primary care and outpatient services, which is a capacity challenge worth taking seriously, but it is a different problem from the emergency department swamping that opponents often predict.
The group that actually uses emergency departments at high rates is adults on Medicaid, at 0.52 visits per year, roughly three times the rate of the privately insured. This likely reflects Medicaid enrollees’ difficulty finding primary care providers who accept their insurance, which is itself a reimbursement rate problem. It suggests that how a universal system is designed, particularly how well it pays primary care providers, matters as much as whether coverage is universal at all.